Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.91 USD | -5.43% |
|
+11.46% | +44.90% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.90% | 2.04B | |
+48.76% | 57.87B | |
+41.65% | 40.25B | |
-6.87% | 39.94B | |
-5.96% | 28.54B | |
+12.78% | 26.4B | |
-20.06% | 19.33B | |
+30.63% | 12.4B | |
-0.22% | 12.23B | |
+24.93% | 12.2B |
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- Protagonist Therapeutics Insider Sold Shares Worth $948,600, According to a Recent SEC Filing